Chong Kun Dang Pharmaceutical (185750) — Cash Flow-to-Debt Ratio
Chong Kun Dang Pharmaceutical (185750) has a Cash Flow-to-Debt Ratio of 0.04x as of September 2025, meaning its operating cash flow of ₩21.45 Billion could theoretically repay 0% of its total liabilities (₩576.36 Billion) in one year. See Chong Kun Dang Pharmaceutical free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Chong Kun Dang Pharmaceutical Cash Flow-to-Debt Ratio (2016–2024)
Historical debt coverage capacity for Chong Kun Dang Pharmaceutical across 9 annual periods. Also explore Chong Kun Dang Pharmaceutical net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Chong Kun Dang Pharmaceutical (2016–2024)
Year-by-year debt coverage analysis for Chong Kun Dang Pharmaceutical. For market capitalisation and broader financial context, see 185750 company net worth.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.11x | ₩64.29 Billion | ₩562.39 Billion | ▼ -78.9% |
| 2023 | 0.54x | ₩318.16 Billion | ₩586.79 Billion | ▲ +303.1% |
| 2022 | 0.13x | ₩67.73 Billion | ₩503.59 Billion | ▲ +401.3% |
| 2021 | 0.03x | ₩12.90 Billion | ₩480.89 Billion | ▼ -89.8% |
| 2020 | 0.26x | ₩104.32 Billion | ₩394.74 Billion | ▲ +11.6% |
| 2019 | 0.24x | ₩77.29 Billion | ₩326.40 Billion | ▲ +55.9% |
| 2018 | 0.15x | ₩42.63 Billion | ₩280.60 Billion | ▼ -49.1% |
| 2017 | 0.30x | ₩81.67 Billion | ₩273.91 Billion | ▲ +48.3% |
| 2016 | 0.20x | ₩57.79 Billion | ₩287.45 Billion | — |